Jemma L. O’Connor

691 total citations
10 papers, 449 citations indexed

About

Jemma L. O’Connor is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Jemma L. O’Connor has authored 10 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Emergency Medicine and 4 papers in Virology. Recurrent topics in Jemma L. O’Connor's work include HIV-related health complications and treatments (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Jemma L. O’Connor is often cited by papers focused on HIV-related health complications and treatments (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Jemma L. O’Connor collaborates with scholars based in United Kingdom, Australia and Denmark. Jemma L. O’Connor's co-authors include Andrew Phillips, Michael J. Vjecha, Jens Lundgren, Álvaro H. Borges, Sarah Pett, Martyn A. French, Frederikke F. Rönsholt, James D. Neaton, Kersten K. Koelsch and Birgit Grund and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Eurosurveillance.

In The Last Decade

Jemma L. O’Connor

9 papers receiving 443 citations

Peers

Countries citing papers authored by Jemma L. O’Connor

Since Specialization

Citations

This map shows the geographic impact of Jemma L. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jemma L. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jemma L. O’Connor more than expected).

Fields of papers citing papers by Jemma L. O’Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jemma L. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jemma L. O’Connor. The network helps show where Jemma L. O’Connor may publish in the future.

Co-authorship network of co-authors of Jemma L. O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Jemma L. O’Connor. A scholar is included among the top collaborators of Jemma L. O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jemma L. O’Connor. Jemma L. O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial 2017 ·The Lancet HIV ·Jemma L. O’Connor, Michael J. Vjecha, Andrew Phillips, Brian Angus, David A. Cooper, Beatriz Grinsztejn, Gustavo Lopardo, Satyajit Das, Robin Wood, Aimee Wilkin, Hartwig Klinker, Pacharee Kantipong, Karin L. Klingman, David Jilich, (unknown), Eileen Denning, Ibrahim Abubakar, Fred M. Gordin, Jens Lundgren	35
2	Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection 2016 ·The Journal of Infectious Diseases ·Álvaro H. Borges, Jemma L. O’Connor, Andrew Phillips, James D. Neaton, Birgit Grund, Jacqueline Neuhaus, Michael J. Vjecha, Alexandra Calmy, Kersten K. Koelsch, Jens Lundgren	98
3	Factors Associated With Plasma IL-6 Levels During HIV Infection 2015 ·The Journal of Infectious Diseases ·Álvaro H. Borges, Jemma L. O’Connor, Andrew Phillips, Frederikke F. Rönsholt, Sarah Pett, Michael J. Vjecha, Martyn A. French, Jens Lundgren	127
4	Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial 2015 ·HIV Medicine ·(unknown), Shweta Sharma, Keikawus Arastéh, David A. Wohl, Amit C. Achhra, Giuseppe Tambussi, Jemma L. O’Connor, James H. Stein, (unknown), (unknown), Andrew Phillips, (unknown)	27
5	Factors Associated with D-Dimer Levels in HIV-Infected Individuals 2014 ·PLoS ONE ·Álvaro H. Borges, Jemma L. O’Connor, Andrew Phillips, Jason V. Baker, Michael J. Vjecha, Marcelo Losso, Hartwig Klinker, Gustavo Lopardo, Ian Williams, Jens Lundgren	66
6	Determinants of IL‐6 levels during HIV infection 2014 ·Journal of the International AIDS Society ·Álvaro H. Borges, Jemma L. O’Connor, Andrew Phillips, Frederikke F. Rönsholt, Sarah Pett, Michael J. Vjecha, Martyn A. French, Jens Lundgren	8
7	Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study 2014 ·Journal of the International AIDS Society ·Jemma L. O’Connor, Colette Smith, Fiona Lampe, Margaret Johnson, Caroline Sabin, Andrew Phillips	4
8	Antiretroviral therapy for prevention of HIV transmission: implications for Europe 2013 ·Eurosurveillance ·Valentina Cambiano, Jemma L. O’Connor, Andrew Phillips, Alison Rodger, Rebecca Lodwick, Anastasia Pharris, Fiona Lampe, Fumiyo Nakagawa, Colette Smith, M J van de Laar	18
9	Factors Associated With Adherence Amongst 5295 People Receiving Antiretroviral Therapy as Part of an International Trial 2012 ·The Journal of Infectious Diseases ·Jemma L. O’Connor, Edward M. Gardner, Sharon Mannheimer, (unknown), Stefan Eßer, Edward E. Telzak, Andrew Phillips	66
10	Evaluating HIV treatment as prevention in the European context. 2012 ·UCL Discovery (University College London) ·Colette Smith, Valentina Cambiano, Jemma L. O’Connor, Fumiyo Nakagawa, Rebecca Lodwick, (unknown), Fiona Lampe, Andrew W. Phillips	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact